Seo Yuri, Jeung Soomin, Kang Sun-Myoung, Yang Won Seok, Kim Hyosang, Kim Soon Bae
Department of Nephrology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kidney Res Clin Pract. 2018 Mar;37(1):85-88. doi: 10.23876/j.krcp.2018.37.1.85. Epub 2018 Mar 31.
Intradialytic hypotension during dialysis adversely affects a patient's prognosis and increases mortality. We report a case in which intradialytic hypotension that persisted after the administration of midodrine was relieved after the use of fludrocortisone. Administration of 0.2 mg of fludrocortisone occurred 30 minutes before dialysis. We compared 45 sessions of dialysis without fludrocortisone administration and 45 sessions of dialysis with fludrocortisone administration in one patient. The number of times in which systolic blood pressure became lower than 80 mmHg and the number of early terminations of dialysis due to a decrease in systolic blood pressure were higher in the sessions without fludrocortisone administration than in the sessions with fludrocortisone administration ( < 0.05). Fludrocortisone may be helpful for the treatment of intradialytic hypotension that does not respond to midodrine administration.
透析期间的透析中低血压会对患者的预后产生不利影响,并增加死亡率。我们报告了一例患者,在使用米多君后仍持续存在的透析中低血压在使用氟氢可的松后得到缓解。在透析前30分钟给予0.2mg氟氢可的松。我们比较了该患者在未使用氟氢可的松的45次透析疗程和使用氟氢可的松的45次透析疗程。未使用氟氢可的松的疗程中收缩压低于80mmHg的次数以及因收缩压下降导致的透析早期终止次数高于使用氟氢可的松的疗程(<0.05)。氟氢可的松可能有助于治疗对米多君治疗无反应的透析中低血压。